Market Context — Why This Technology, Why Now

The increasing global burden of chronic diseases and rising healthcare costs are accelerating demand for proactive health management. Consumers are actively seeking science-backed solutions for anti-aging and disease prevention, driving significant growth in the functional food and supplement markets. This technology aligns perfectly with this trend, offering a novel, natural-ingredient-based solution that could differentiate products in a competitive landscape and address a multi-billion dollar wellness market.

Key Competitive Advantages
01

Provides a unique mechanism of action, making it difficult for competitors to replicate due to minimal prior art.

02

Offers a fundamental approach to oxidative stress-induced diseases by inducing mitochondrial ferritin (FtMt), unlike symptomatic treatments.

03

Reduces product development risk due to the high safety and market acceptance of curcumin or its derivatives as natural ingredients.

Market Opportunity
Functional Foods & Supplements
$250B–$350B globally (AI est.)
This technology, leveraging natural curcumin, is highly suitable for functional foods and dietary supplements targeting general wellness, anti-aging, and disease prevention, aligning with strong consumer demand for natural health solutions.
Major functional food manufacturers Global dietary supplement brands Health and wellness product developers
Pharmaceuticals & Therapeutics
$50B–$100B globally (AI est.)
The fundamental approach to oxidative stress and its broad applicability to diseases like neurodegenerative, cardiovascular, and cancer conditions positions this technology for high-value pharmaceutical development.
Biotech firms focused on neurodegenerative diseases Pharmaceutical companies developing cardiovascular therapies Oncology drug developers
Cosmeceuticals & Anti-Aging
$50B–$100B globally (AI est.)
Oxidative stress is a key factor in skin aging and overall age-related decline. This technology offers a novel internal mechanism for anti-aging effects, making it valuable for cosmeceutical and beauty applications.
Leading skincare and beauty brands Cosmeceutical ingredient suppliers Anti-aging product innovators
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a unique composition for inducing mitochondrial ferritin expression using curcumin or its derivatives. Its robust claims and minimal prior art suggest a strong, defensible position against competitors, making it difficult to imitate.

Competitive White Space

This patent protects specific curcumin-based FtMt induction. A licensee could explore novel FtMt-inducing compounds, advanced delivery systems, or diagnostic methods for FtMt levels.

Economic Impact
~$5M/year estimated additional profit per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming a $20B global preventive healthcare market (AI est.), and a 0.5% market share for products based on this technology, annual sales could reach ~$100M (AI est.). Achieving a 5% higher gross margin (45%) due to product differentiation could generate ~$5M in additional annual profit (AI est.).

Speed to Market
4× faster than in-house development
Curcumin and its derivatives, the active ingredients, have extensive existing safety data for food and pharmaceutical applications. The patent specifies the mechanism of mitochondrial ferritin induction, significantly shortening new compound discovery and basic research phases. This allows for efficient formulation, clinical trials, and product commercialization, reducing development time by approximately 2.5 years compared to in-house development.
Competitive Positioning

X: Mechanism Specificity
Y: Multi-Disease Applicability

Business Models & Applications
💊 Licensing for Functional Foods & Supplements
Licensing this technology as an active ingredient for functional foods could enable companies to create new product categories in the health food market and diversify revenue streams.
🔬 Collaborative R&D in Pharmaceuticals
Entering joint R&D agreements for drug development in specific medical fields, such as neurodegenerative or cardiovascular diseases, could lead to entry into high-value pharmaceutical markets.
🏭 Ingredient Supply for Partner Ecosystems
Supplying ingredients based on this technology to OEM/ODM manufacturers could accelerate market entry for various brands and foster value creation across the supply chain.
Adjacent Application Opportunities
💆‍♀️ Beauty & Anti-Aging
Inner Beauty & Functional Cosmetics
This technology could be applied to beauty supplements and functional cosmetics to combat oxidative stress, a primary cause of skin aging and UV damage. By activating mitochondria for internal anti-aging effects, it could innovate the ~$60 billion global anti-aging skincare market.
🐾 Pet Care
Pet Longevity Supplements
Applicable as functional pet food or supplements to extend the healthy lifespan of pets like dogs and cats. It could help prevent and improve various age-related pet diseases, such as cognitive decline and arthritis, creating new opportunities in the ~$20 billion global pet care market.
💪 Sports Nutrition
Athlete Recovery Support
This technology could be used in athlete recovery supplements and functional drinks to reduce oxidative stress and fatigue from high-intensity training. By promoting mitochondrial function for sustained performance and recovery, it could capture a share of the ~$40 billion global sports nutrition market.
Integration Roadmap — Estimated 17-Month Deployment
Phase 1: Technology Compatibility & Formulation Design
Duration: 4 months
Evaluate active ingredient stability, verify compatibility with existing product lines, and conduct initial formulation design to establish the foundation for commercialization.
Phase 2: Prototyping & Safety/Efficacy Evaluation
Duration: 9 months
Conduct small-batch prototype manufacturing, non-clinical trials, or functional evaluation tests to collect safety and efficacy data. Simultaneously prepare for regulatory applications.
Phase 3: Product Commercialization & Market Launch
Duration: 4 months
Establish mass production systems, formulate marketing strategies, and obtain final regulatory and food labeling approvals to launch products into the market.
Technical Feasibility
This technology, a composition patent for curcumin or its derivatives, can be relatively easily integrated into existing pharmaceutical and functional food manufacturing processes. No specific new equipment investment is required, and efficient utilization in production lines is expected through formulation adjustments for powders or liquids.
Success Scenario
Adopting this technology could enable companies to build high-value product lines centered on mitochondrial function improvement. For instance, new functional foods entering the market could contribute to extending consumer health spans, with related product sales estimated to grow to ~$3M–$7M annually within three years (AI est.). This could enhance brand value and attract new customers.
Patent Record
APPLICATION NO.
特願2020-144256
REGISTRATION NO.
7496123
FILING DATE
2020年08月28日
GRANT DATE
2024年05月29日
EXPIRATION DATE
2040年08月28日
PATENT HOLDER
国立大学法人滋賀医科大学
Examination History
2023年06月20日
出願審査請求書
2024年05月14日
特許査定